Proteus Mirabilis

• Rx Only*

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

1. 1Neoplasm Malignant412%
2. 2Drug Dose Omission39.1%
3. 3Fatigue39.1%
4. 4Neuropathy Peripheral39.1%
5. 5Cancer Surgery26.1%
6. 6Confusional State26.1%
7. 7Death26.1%
8. 8Diarrhoea26.1%
9. 9Dizziness26.1%
10. 10Drug Ineffective26.1%
11. 11Dyspepsia26.1%
12. 12Heart Rate Decreased26.1%
13. 13Infection26.1%
14. 14Memory Impairment26.1%
15. 15Nausea26.1%

Recent PubMed references pinned to Proteus Mirabilis as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Contribution of three tRNA modification enzymes to Proteus mirabilis fitness and catheter-associated urinary tract infection.
  Infection and immunity · 2026 · Brix V, Hunt BC, Learman BS, et al.
  PMID 42037426DOI 10.1128/iai.00722-25
• Isolation, Identification and Pathogenicity Analysis of Proteus mirabilis in Cynomolgus Monkey From Yunnan, China.
  Veterinary medicine and science · 2026 · Li H, Qian Z, Luo L, et al.
  PMID 41954268DOI 10.1002/vms3.70921
• Comparative genomic analysis of extensively drug-resistant Proteus mirabilis co-producing VIM-1 and OXA-48 carbapenemases.
  Journal of global antimicrobial resistance · 2026 · Mavroidi A, Froukala E, Koumaki V, et al.
  PMID 41932438DOI 10.1016/j.jgar.2026.03.015
• A lytic phage targeting virulent Proteus mirabilis for effective biofilm eradication.
  Microbial pathogenesis · 2026 · Ma W, Li P, Zhou X, et al.
  PMID 41895349DOI 10.1016/j.micpath.2026.108469
• Molecular structure and nickel-binding capacity of Proteus mirabilis UreE.
  Acta crystallographica. Section D, Structural biology · 2026 · Pan J, Mueller SL, Tasneem N, et al.
  PMID 41834538DOI 10.1107/S2059798326001907
• A case of infective endocarditis following urinary tract infection by Proteus mirabilis.
  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2025 · Maruyama K, Harada N, Katsumata H, et al.
  PMID 41810592DOI 10.1016/j.jiac.2025.102839
• Biotransformation of Allium Sulfur Metabolites by Proteus mirabilis Yields Cepathiosoxide, a Trithiabicyclic Sulfoxide.
  Organic letters · 2026 · Lee J, Sung Y, Nam Y, et al.
  PMID 41784040DOI 10.1021/acs.orglett.6c00329
• Detection of OXA-23 and OXA-58 in Proteus mirabilis by immunochromatographic assays.
  Microbiology spectrum · 2026 · Noster-Schrader J, Sattler J, Stoll Y, et al.
  PMID 41757932DOI 10.1128/spectrum.01899-25

The 4 most recently updated of 4 ClinicalTrials.gov registrations naming Proteus Mirabilis as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• PRObiotics for KIdney Transplantation
  Enrolling by invitation · Interventional · 132 enrolled · University Hospital, Udine, Italy
  NCT06825117updated 2025-02-13
• Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis
  Completed · Observational · 67 enrolled · Dokuz Eylul University
  NCT06542965updated 2024-08-07
• Randomized Double-Blind Controlled Clinical Trial
  Completed · Interventional · 25 enrolled · SerenaGroup, Inc.
  NCT04320628updated 2022-03-14
• Effect of Emergency Department Care Reorganization on Door-to-antibiotic Times for Sepsis (LDS SWARM)
  Completed · Observational · 3,230 enrolled · Intermountain Health Care, Inc.
  NCT03226366updated 2020-06-18

Frequently asked questions

What is Proteus Mirabilis used for?

According to FDA labeling, Proteus Mirabilis carries indications including: Rx Only*. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.